Authors: Kluin-Nelemans, HC Zagonel, V Anastasopoulou, A Bron, D Roozendaal, KJ Noordijk, EM Musson, H Teodorovic, I Maes, B Carbone, A Carde, P Thomas, J

Citation: Hc. Kluin-nelemans et al., Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: Randomized phase III EORTC study, J NAT CANC, 93(1), 2001, pp. 22-30

Authors: Vermorken, JB Zanetta, G Oliveira, CFD van der Burg, MEL Lacave, AJ Teodorovic, I Boes, GH Colombo, N

Citation: Jb. Vermorken et al., Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma ofthe uterine cervix: An EORTC Gynecological Cancer Cooperative Group study, ANN ONCOL, 12(7), 2001, pp. 967-974

Authors: Maes, B Anastasopoulou, A Kluin-Nelemans, JC Teodorovic, I Achten, R Carbone, A De Wolf-Peeters, C

Citation: B. Maes et al., Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+anaplastic B-cell subtypes exhibit distinct clinical features, ANN ONCOL, 12(6), 2001, pp. 853-858